Addex Therapeutics Ltd
ADXN
Price:
$7.53
Market Cap:
$10.34M
Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of oral small molecule allosteric modulators of G-protein coupled receptors. Its lead programs include Dipraglurant for the treatment of Parkinson's disease levodopa-induced dyskinesia, and dystonia; ADX71149 for epilepsy and undisclosed CNS disorders; and GABAB PAM for addiction. It has license and collaboration agreement with Janssen Pharmaceuticals Inc.; Indivior PLC; and The CharcotMarieTooth Association. The company was formerly known as Addex...[Read more]
Industry
Biotechnology
IPO Date
2020-02-12
Stock Exchange
NASDAQ
Ticker
ADXN
PE Ratio
[-0.40]
ROE
[105.53%]
Current Ratio
[4.97]
Dividend Yield
[0%]
Enterprise Value
[6.58M]
Dividend History
The ROE as of November 2024 (TTM) for Addex Therapeutics Ltd (ADXN) is 105.53%
According to Addex Therapeutics Ltd’s latest financial reports and current stock price. The company's current ROE is 105.53%. This represents a change of 3.92% compared to the average of 2.63% of the last 4 quarters.
Addex Therapeutics Ltd (ADXN) Historical ROE (quarterly & annually)
How has ADXN ROE performed in the past?
The mean historical ROE of Addex Therapeutics Ltd over the last ten years is -359.92%. The current 105.53% ROE has changed -129.32% with respect to the historical average. Over the past ten years (40 quarters), ADXN's ROE was at its highest in in the March 2024 quarter at 224.46%. The ROE was at its lowest in in the September 2016 quarter at -380.72%.
Average
-359.92%
Median
-167.51%
Minimum
-1440.76%
Maximum
-4.19%
Addex Therapeutics Ltd (ADXN) ROE by Quarter and Year
Discovering the peaks and valleys of Addex Therapeutics Ltd ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.28%
Maximum Annual ROE = -4.19%
Minimum Annual Increase = -98.28%
Minimum Annual ROE = -1440.76%
| Year | ROE | Change |
|---|---|---|
| 2023 | -921.57% | 117.63% |
| 2022 | -423.46% | 367.02% |
| 2021 | -90.67% | 3.02% |
| 2020 | -88.01% | 51.99% |
| 2019 | -57.91% | 1.28% |
| 2018 | -4.19% | -98.28% |
| 2017 | -244.35% | -83.04% |
| 2016 | -1440.76% | 470.32% |
| 2015 | -252.62% | 233.87% |
| 2014 | -75.66% | -84.17% |
Addex Therapeutics Ltd (ADXN) Average ROE
How has ADXN ROE performed in the past?
The current ROE of Addex Therapeutics Ltd (ADXN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-478.57%
5-year avg
-316.32%
10-year avg
-359.92%
Addex Therapeutics Ltd (ADXN) ROE vs. Peers
How is ADXN’s ROE compared to its peers?
Addex Therapeutics Ltd’s ROE is greater than Innate Pharma S.A. (-84.39%), greater than Aptorum Group Limited (-12.10%), greater than Celyad Oncology SA (-170.72%), greater than Dyadic International, Inc. (-149.17%), greater than Aceragen, Inc. (-68.32%), greater than ERYTECH Pharma S.A. (-0.98%), greater than Soligenix, Inc. (-223.76%), greater than Avenue Therapeutics, Inc. (-473.61%), greater than Kronos Bio, Inc. (-64.55%), greater than Cyclerion Therapeutics, Inc. (-55.31%), greater than Larimar Therapeutics, Inc. (-35.87%), greater than Achilles Therapeutics plc (-54.57%),
| Company | ROE | Market cap |
|---|---|---|
| -84.39% | $131.95M | |
| -12.10% | $3.83M | |
| -170.72% | $14.24M | |
| -149.17% | $57.11M | |
| -68.32% | $3.24M | |
| -0.98% | $47.38M | |
| -223.76% | $8.31M | |
| -473.61% | $3.84M | |
| -64.55% | $54.49M | |
| -55.31% | $3.88M | |
| -35.87% | $393.05M | |
| -54.57% | $43.57M |
Build a custom stock screener for Addex Therapeutics Ltd (ADXN) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Addex Therapeutics Ltd using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Addex Therapeutics Ltd (ADXN) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Addex Therapeutics Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Addex Therapeutics Ltd's ROE?
How is the ROE calculated for Addex Therapeutics Ltd (ADXN)?
What is the highest ROE for Addex Therapeutics Ltd (ADXN)?
What is the 3-year average ROE for Addex Therapeutics Ltd (ADXN)?
What is the 5-year average ROE for Addex Therapeutics Ltd (ADXN)?
How does the current ROE for Addex Therapeutics Ltd (ADXN) compare to its historical average?